(Boursier.com) — In the first half of 2021, the Group’s unaudited consolidated revenue Aegis is virtually stable at €16.02 million (€16.6 million and €15.9 million in the second half of 2021). The Euro/Dollar parity is favorable since at constant dollar the turnover would be lower by 8.1%.
These figures are lower than expected. Egide SA continues its growth and consolidates its leading position in the thermal imaging market in Europe (particularly with the acquisition of new customers), in Asia (China and South Korea) and in the Middle East. Egide USA is still suffering from the labor shortage in the United States, despite the adjustment of salary scales to levels higher than those of the market. Out of a target workforce of 95 employees, he missed up to 15 people. Santier’s business was also disrupted to a lesser extent by the tight labor market, and supply chain issues continue to hamper production
Outlook
Egide SA intends to continue its growth in 2022 and accelerate it in 2023.
Egide USA and Santier should finalize the financing of the working capital requirement in the coming days, which will allow them to focus on production and customer satisfaction.
The Egide Group recalls that it should finalize its plan to transfer the listing of its shares to the Euronext Growth market in Paris by the end of August 2022. This plan aims to enable Egide to be listed on a more appropriate to the size of the company. The transfer to the Paris market of Euronext Growth would simplify the operation of the company and reduce its listing costs, while allowing it to continue to benefit from the advantages of a listing on a financial market.
©2022 Boursier.com